Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease Post author: Post published:October 24, 2024 Post category:News Feed Post comments:0 Comments Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). You Might Also Like Study finds health risks in switching ships from diesel to ammonia fuel July 12, 2024 Could a dietary fiber supplement offer long-awaited treatment for food allergy sufferers? July 10, 2024 Weight-loss drug reduces risk of early death for patients with heart failure, trial finds November 21, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Could a dietary fiber supplement offer long-awaited treatment for food allergy sufferers? July 10, 2024
Weight-loss drug reduces risk of early death for patients with heart failure, trial finds November 21, 2024